The UMBRELLA consortium, led by Vall d'Hebron Research Institute (VHIR), a member of CATALONIA.HEALTH, and the company Siemens Healthineers, is made up of more than 20 public and private partners whose objective is to revolutionize the entire stroke care process in Europe. The consortium starts with the aim of revolutionizing the entire stroke care process in Europe by adopting a holistic approach that covers the diagnosis, prevention and care of stroke.
The UMBRELLA project takes advantage of the potential of artificial intelligence (AI) and the most cutting-edge digital technologies to transform stroke diagnosis, reduce treatment time and improve long-term clinical outcomes. It also contributes to a better understanding of stroke and its underlying causes to advance prevention strategies.
The Innovative Health Initiative (IHI), a collaboration between the European Union's Horizon Europe research and innovation programme, and the industrial associations COCIR, EFPIA, Europa Bio, MedTech Europe and Vaccines Europe, together with industrial partners, will finance the UMBRELLA project with nearly €27 million over the next five years.
One of the objectives of the project is to build a federated data platform that will serve as a basis for creating and validating AI algorithms based on retrospective data collected throughout the consortium, allowing advanced personalized diagnoses, predicting risks and making treatment decisions for stroke patients. It will also create and apply standardised protocols and procedures for stroke treatment to participating centres, with a view to their adoption in official European protocols.
"UMBRELLA represents a revolution in stroke care that will accelerate access to innovative, personalized and front-line diagnoses and treatments for thousands of patients in Europe," says Dr. Carlos Molina, head of the Neurology Service at Vall d'Hebron University Hospital, head of the Ictus Research Group at the Vall d'Hebron Research Institute and scientific coordinator of the project.
Comments